- FDA bans controversial red dye found in candy, drinks and snacks (washingtonpost.com)
- The FDA targets pharma’s grip on costly, toxic cancer drug dosages (washingtonpost.com)
- Philips’ US sales of sleep apnea devices face years-long halt after FDA deal (reuters.com)
- Millions of People Used Tainted Breathing Machines. The FDA Failed to Use Its Power to Protect Them. (propublica.org)
- Billed as nonaddictive, new pain pill could soon win FDA approval – but questions remain (washingtonpost.com)
- PhRMA mess: US pharma group urging FDA power over abortion pill also backs Republicans who oppose drug (theguardian.com)
- Congressional Watchdog Will Launch Inquiry Into FDA Oversight of Medical Device Recalls (propublica.org)
- Robert F. Kennedy Jr. Says Entire Departments Of The FDA ‘Have To Go’ (huffpost.com)
- FDA Repeatedly Rejected Safety Claims Made by Philips After the CPAP Recall but Waited to Alert the Public, Emails Show (propublica.org)
- FDA issues warning about counterfeit Ozempic after seizing ‘thousands’ of units (nydailynews.com)
